Drug maker Ajanta Pharma’s new formulations facility set up at Guwahati with a capex of over Rs 300 crore is likely to be commercialised before March 2017. This will enable the company to build its strength in manufacturing and get more tax efficient. The facility will produce tablets, capsules, creams/ointments and sterile ophthalmic liquids.
Moreover, the company’s Dahej manufacturing facility, mainly dedicated for developed markets, will be operational in next financial year.
Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. The company is engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.
